- Long-term Disease-free Survival after Trimodality Treatment of Recurrent Hepatocellular Carcinoma Involving the Inferior Vena Cava and Right Atrium
-
Park S, Yoon WS, Yim HJ, Rim CH
- KMID: 2463616
- J Liver Cancer.
- 2019 Sep;19(2):149-153.
- doi: 10.17998/jlc.19.2.149
Hepatocellular carcinoma (HCC) involving the inferior vena cava (IVC) and/or right atrium (RA) is a rare and intractable disease. A standard treatment has not been established yet, owing to the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
-
Ock CY, Yoo SH, Keam B, Kim M, Kim TM, Jeon YK, Kim DW, Chung DH, Heo DS
- KMID: 2457035
- Korean J Intern Med.
- 2019 Sep;34(5):1116-1124.
- doi: 10.3904/kjim.2018.011
BACKGROUND/AIMS: Although crizotinib is standard chemotherapy for advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), clinical factors affecting progression-free survival (PFS) have not been reported. The purpose of... -
- CITED
-
- Close
- SHARE
-
- Close
- Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes
-
Joo JH, Kim SS, Son BH, Ahn SD, Jung JH, Choi EK, Ahn SH, Lee JW, Kim HJ, Ko BS
- KMID: 2454293
- Cancer Res Treat.
- 2019 Jul;51(3):1011-1021.
- doi: 10.4143/crt.2018.438
PURPOSE: Axillary lymph node dissection (ALND) may be avoidable for breast cancer patients with 1-2 positive lymph nodes (LN) after breast-conserving therapy. However, the effects of ALND after mastectomy remain... -
- CITED
-
- Close
- SHARE
-
- Close
- Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
-
Kang HW, Park H, Seo SP, Byun YJ, Piao XM, Kim SM, Kim WT, Yun SJ, Jang W, Shon HS, Ryu KH, Lee SC, Kim WJ, Kim YJ
- KMID: 2445802
- J Korean Med Sci.
- 2019 May;34(19):e144.
- doi: 10.3346/jkms.2019.34.e144
BACKGROUND: Little is known about epigenetic silencing of genes by promoter hypermethylation in renal cell carcinoma (RCC). The aim of this study was to identify prognostic methylation markers in surgically... -
- CITED
-
- Close
- SHARE
-
- Close
- EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
-
Park SE, Noh JM, Kim YJ, Lee HS, Cho JH, Lim SW, Ahn YC, Pyo H, Choi YL, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ
- KMID: 2464396
- Cancer Res Treat.
- 2019 Apr;51(2):493-501.
- doi: 10.4143/crt.2018.125
PURPOSE: This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival
-
Oh J, Lee JM, Park J, Joo I, Yoon JH, Lee DH, Ganeshan B, Han JK
- KMID: 2440480
- Korean J Radiol.
- 2019 Apr;20(4):569-579.
- doi: 10.3348/kjr.2018.0501
OBJECTIVE: To investigate the usefulness of computed tomography (CT) texture analysis (CTTA) in estimating histologic tumor grade and in predicting disease-free survival (DFS) after surgical resection in patients with hepatocellular... -
- CITED
-
- Close
- SHARE
-
- Close
- Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
-
Tseng JS, Yang TY, Chen KC, Hsu KH, Huang YH, Su KY, Yu SL, Chang GC
- KMID: 2424789
- Cancer Res Treat.
- 2018 Oct;50(4):1164-1174.
- doi: 10.4143/crt.2017.460
PURPOSE: Epidermal growth factor receptor (EGFR) T790M mutation serves as an important predictor of osimertinib efficacy. However, little is known about how it works among patients with various timings of... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Let-7a and H19 Signature: A Prognostic Index of Progression-Free Survival in Primary Breast Cancer Patients
-
Guo Q, Wen R, Shao B, Li Y, Jin X, Deng H, Wu J, Su F, Yu F
- KMID: 2413932
- J Breast Cancer.
- 2018 Jun;21(2):142-149.
- doi: 10.4048/jbc.2018.21.2.142
PURPOSE: The long non-coding RNA H19, a conservatively imprinted gene, acts as a molecular sponge for the let-7 family, which has been identified as a set of tumor suppressors. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors of Atypical Meningioma: Overall Survival Rate and Progression Free Survival Rate
-
Lee JH, Kim OL, Seo YB, Choi JH
- KMID: 2395785
- J Korean Neurosurg Soc.
- 2017 Nov;60(6):661-666.
- doi: 10.3340/jkns.2017.0303.008
OBJECTIVE: Atypical meningioma is rare tumor and there is no accurate guide line for optimal treatment. This retrospective study analyzed the prognostic factors, the effect of different methods of treatments... -
- CITED
-
- Close
- SHARE
-
- Close
- Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
-
Paik ES, Sohn I, Baek SY, Shim M, Choi HJ, Kim TJ, Choi CH, Lee JW, Kim BG, Lee YY, Bae DS
- KMID: 2388309
- Cancer Res Treat.
- 2017 Jul;49(3):635-642.
- doi: 10.4143/crt.2016.282
PURPOSE: This study was conducted to evaluate the prognostic significance of pre-treatment complete blood cell count (CBC), including white blood cell (WBC) differential, in epithelial ovarian cancer (EOC) patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence
-
Kim MY, Kim JH, Kim Y, Byun SJ
- KMID: 2366051
- Radiat Oncol J.
- 2016 Dec;34(4):297-304.
- doi: 10.3857/roj.2016.01879
PURPOSE: To investigate the outcomes of postoperative radiotherapy (RT), in patients with extrahepatic bile duct (EHBD) cancer by comparing the survival rate between patients undergoing surgery alone or surgery plus... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Metabolic Tumor Volume on 11C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma
-
Yoo MY, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, Kang KW
- KMID: 2132234
- Nucl Med Mol Imaging.
- 2015 Dec;49(4):291-297.
- doi: 10.1007/s13139-015-0362-0
PURPOSE: C-11 methionine (MET) PET is commonly used for diagnosing high-grade glioma (HGG). Recently, volumetric analysis has been widely applied to oncologic PET imaging. In this study, we investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib
-
Park DI, Kim SY, Kim JO, Jung SS, Park HS, Moon JY, Chung CU, Kim SS, Seo JH, Lee JE
- KMID: 2320699
- Tuberc Respir Dis.
- 2015 Oct;78(4):315-320.
- doi: 10.4046/trd.2015.78.4.315
BACKGROUND: The efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy can be measured based on the rate of treatment response, based on the Response Evaluation Criteria in... -
- CITED
-
- Close
- SHARE
-
- Close
- Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer
-
Park MR, Park YH, Choi JW, Park DI, Chung CU, Moon JY, Park HS, Jung SS, Kim JO, Kim SY, Lee JE
- KMID: 1842967
- Tuberc Respir Dis.
- 2014 May;76(5):218-225.
- doi: 10.4046/trd.2014.76.5.218
BACKGROUND: Small cell lung cancer (SCLC) is an extremely aggressive tumor with a poor clinical course. Although many efforts have been made to improve patients' survival rates, patients who survive... -
- CITED
-
- Close
- SHARE
-
- Close
- Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer
-
Kim J, Lim ST, Na CJ, Han YH, Kim CY, Jeong HJ, Sohn MH
- KMID: 2139215
- Nucl Med Mol Imaging.
- 2014 Mar;48(1):33-40.
PURPOSE: We performed this study to evaluate the predictive value of pretreatment F-18 FDG PET/CT for progression-free survival (PFS) in patients with gastric cancer. METHODS: Of 321 patients with a diagnosis... -
- CITED
-
- Close
- SHARE
-
- Close
- The optimal follow-up period in patients with above 5-year disease-free survival after curative liver resection for hepatocellular carcinoma
-
Ahn SH, Kim SH, Choi GH, Choi JS, Kim KS
- KMID: 2212548
- J Korean Surg Soc.
- 2013 Dec;85(6):269-274.
- doi: 10.4174/jkss.2013.85.6.269
PURPOSE: Although many patients with hepatocellular carcinoma experience recurrence within 2 years after hepatectomy, some patients with T1 and T2 hepatocellular carcinoma show recurrence-free survival for more than 5 years... -
- CITED
-
- Close
- SHARE
-
- Close
- Twist Expression in Upper Urinary Tract Urothelial Carcinoma Affects Patients Disease Free Survival and is Associated with Tumor Grade
-
Kim DI, Yoon SO, Park SY, Kim B, Kang GH, Moon KC
- KMID: 1521626
- Korean J Pathol.
- 2007 Oct;41(5):324-328.
BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for morphogenesis during embryonic development and is also implicated in the conversion of early-stage tumors into invasive malignancies. Recently, Twist has been identified to... -
- CITED
-
- Close
- SHARE
-
- Close
- Ten Year Disease-free Survival of a Patient after Modified Hepatoligamentopancreatoduodenectomy for Diffuse Hilar Cholangiocarcinoma with Paraaortic Lymph Node Metastases: A Case Report
-
Jung DH, Lee SG, Kim MH, Sung GB
- KMID: 2244483
- Korean J Hepatobiliary Pancreat Surg.
- 2006 Sep;10(3):42-46.
A 39-year-old female patient presenting with epigastric discomfort and jaundice was diagnosed as diffuse hilar cholangiocarcinoma with vascular tumor invasion. After preoperative management with percutaneous transhepatic biliary drainage and right... -
- CITED
-
- Close
- SHARE
-
- Close
- Can 3-year Disease-free Survival be Substituted for 5-year Overall Survival in Curatively Resected Gastric Cancer?
-
Kwon SJ, Kim HJ, Kim MK
- KMID: 2372779
- J Korean Gastric Cancer Assoc.
- 2005 Sep;5(3):174-179.
PURPOSE: The 5-year survival rate is the most useful parameter for evaluating the effect of management on most malignant tumors. Recurrence after a curative resection for gastric cancer occurs mostly... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Long-Term Survival and Disease Free Survival after Liver Resection for Hepatocelluar Carcinoma
-
Yun HR, Lee KW, Heo JS, Choi SH, Kim SJ, Kim YI, Joh JW
- KMID: 1844419
- J Korean Surg Soc.
- 2005 Jun;68(6):479-486.
PURPOSE: Liver resection has been the treatment of choice for a hepatocellular carcinoma (HCC) but the survival rates remain low, and recurrences common. The purpose of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
